Great lecture on Lithium by Dr. Meyer!
✨Clinical Pearls✨ Dr. Jonathan Meyer discusses lithium-related renal monitoring and describes how to treat lithium-related polyuria. NEI Members can watch the full lecture at https://nei.global/encore Presented by Dr. Jonathan Meyer at the 2023 NEI Congress, session titled, "Lithium 101: Hit the Road, Jack, if You Don't Know About ENaC" Learn about upcoming NEI Meetings https://lnkd.in/e_359k2J
Driven Regulatory Affairs professional with over 25 years experience in the Medical Device industry looking for a remote position
Check out these presentations by Matthew Mace from Acorai to learn about the upcoming alternatives in managing Heart Failure.
Exciting news! Our chief scientific officer, Matthew Mace, will present twice today at the Frankfurt CSI congress First up, catch him at the start-up competition in the Pink room at 16:15 CEST. Matthew will be sharing the latest data from the world of Acorai - you won't want to miss it! Immediately following, join Matthew and some esteemed colleagues in the Yellow Room at 17:30 for a session on other device-based heart failure therapies. Make sure to mark your calendars and attend these presentations. Matthew will be in Frankfurt until the end of the congress on Saturday. See you there! #CSIcongress #Acorai #HeartFailureTherapies #FrankfurtPresentation
Dr. Nishtha Sodhi Sood (@NishthaSodhi) introduces our latest issue showcasing advanced techniques in contemporary vascular interventions, including mitral, tricuspid, aortic, and pulmonary.
Encouraging and participating in high-quality interventional procedures research should be a top priority. Read more in this update from the Interventional Procedures Section. Read the full article: https://hubs.la/Q02lxchC0
This study investigates the feasibility of using QFR in Heart Team discussions for determining optimal revascularization strategies in patients with MVD. It found substantial agreement between the QFR and FFR methods, suggesting that QFR is a viable non-invasive alternative to FFR. This could simplify the decision-making process in clinical settings by reducing reliance on invasive FFR measurements and potentially speeding up procedural times. Taku Asano MD, PhD https://ow.ly/qjN850S3Orv Check out also the Editorial by Patrick W. Serruys; @Pruthvi C. Revaiah 👉 https://ow.ly/pB8550S3OQH
Join us in honoring all the researchers, clinicians, and trial participants who contribute to the advancement of medicine on this #ClinicalTrialsDay. Your tireless efforts bring us one step closer to a healthier future. Our DurAVR™ THV First-in-Human and Early Feasibility Study clinical trials have allowed us to continuously refine and improve our transcatheter heart valve system to treat patients with aortic stenosis. We are rigorously testing our products and preparing for a larger pivotal clinical trial poised to lead to market approval. Learn more about our current clinical data here: https://lnkd.in/gvMsnjRM Christopher Meduri, Anita Asgar, Azeem Latib, Edwin Ho, Andreas Scotti, Stanley Chetcuti, Gorav Ailawadi, MD, MBA, P Michael Grossman, Sinichi Fukuhara, Maia Zhividze, Rishi Puri, Thomas E. Waggoner, DO, FACC, FSCAI, FSVM, RPVI, Vinayak Bapat, Tamaz Shaburishvili, Teona Zirakashvili
Check out the post below 👇 for insights on how EmboCept® S DSM 50 µm has been an invaluable tool, offering patients an effective and comfortable treatment option. #MagleGroup #MaglePharmaCept #EmboCept®SDSM50µm
In an interview with Interventional News, professors Roberto Iezzi, MD, fCIRSE and Prof. Dr. med. Thomas Albrecht, FRCR shared how EmboCept® S DSM 50 µm has been an invaluable “tool in their toolbox”, offering patients an effective & comfortable treatment option. EMEA physicians, Check out the full interview here: https://lnkd.in/eqm6ZRKq
Delving into cutting-edge research, Scott Goates, member of MDIC's Science of Patient Input Steering Committee, collaborated on a groundbreaking study contrasting transcatheter and surgical mitral valve repair. This study underscores the critical role of integrating #patientpreference data with clinical outcomes, aligning with FDA's Patient Preference Initiative. Uncover the insights in the research published in JAHA — Journal of the American Heart Association. Read more at https://lnkd.in/eJyX_xNQ
Diving into the latest findings from some of our Congenital Cardiac Research Collaborative doctors & others on the Harmony self-expanding transcatheter pulmonary valve replacement demonstrating promising outcomes in reshaping cardiac interventions.
Exciting new publication with Bryan Goldstein, Athar Qureshi, Brian Morray, Jeffrey Zampi, and others! Newly published research highlights the early outcomes of patients with moderate or greater pulmonary regurgitation receiving the Harmony self-expanding TPVR. With 99% freedom from adverse events at 1 year, the Harmony TPVR demonstrates promising results in addressing RVOT dysfunction. Read full publication here: tinyurl.com/2ky52hvv
EMEA HCPs: Did you miss this sponsored session on coronary thrombus management at EuroPCR 2024? Tune in for insights into the latest ESC guidelines, strategies to prevent and treat no reflow, and an examination of trials like TASTE, TAPAS, and TOTAL on coronary thrombus management. Also explore the outcomes of the CHEETAH study, pondering a potential paradigm shift, and delve into a case study on thrombus removal in a patient with high thrombus burden. Moderated by Prof. Andrew Sharp. Featuring speakers Prof. Lang, Dr. Mathews, and Prof. Iglesias. · Learn state of the art, current ESC guidelines and new clinical evidence · Learn how to treat high thrombus burden · Learn about no reflow and potential mechanisms to prevent and treat this Available now: https://bit.ly/4dWYSrb #EuroPCR Clinical results may vary.
Imagine a reality where every breath is a struggle. For 12 million people in the UK, who will develop a lung condition in their lifetime, there’s no need to imagine. Every 5 minutes someone dies from a lung condition, yet public research funding for respiratory research has been chronically low. Saving and improving the lives of people with lung conditions starts with an accurate and timely diagnosis, something that can only be achieved with more research and more funding to develop the understanding and tools needed. Read our collaborative report with LifeArc to hear what people living with a lung condition, clinicals, academic, innovators are proposing to transform the future of respiratory diagnostics and save lives. https://lnkd.in/excBjS8w X ALUK diagnstics&utm_id=
